Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling  by Singec, Ilyas et al.
Stem Cell Reports
ResourceQuantitative Analysis of Human Pluripotency and Neural Specification by
In-Depth (Phospho)Proteomic Profiling
Ilyas Singec,1,7,* Andrew M. Crain,1 Junjie Hou,2,8 Brian T.D. Tobe,1 Maria Talantova,1 Alicia A. Winquist,1
Kutbuddin S. Doctor,3 Jennifer Choy,1 Xiayu Huang,3 Esther La Monaca,4 David M. Horn,5 Dieter A. Wolf,2
Stuart A. Lipton,1 Gustavo J. Gutierrez,1,4 Laurence M. Brill,2,6,9,* and Evan Y. Snyder1,6,*
1Center for Stem Cells and Regenerative Medicine
2Proteomics Facility
3Informatics and Data Management
Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA
4Department of Biology, Vrije Universiteit Brussel, 1050 Brussels, Belgium
5Thermo Fisher Scientific Inc., San Jose, CA 95134, USA
6Co-senior author
7Present address: NIH Regenerative Medicine Program, Stem Cell Translation Laboratory (SCTL), National Center for Advancing Translational Sciences
(NCATS), Rockville, MD 20892, USA
8Present address: National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of
Sciences, Beijing 100101, China
9Present address: Intertek Pharmaceutical Services, Bioanalytical and Proteomic LCMS, San Diego, CA 92121, USA
*Correspondence: ilyas.singec@nih.gov (I.S.), lbrill@san.rr.com (L.M.B.), esnyder@sbpdiscovery.org (E.Y.S.)
http://dx.doi.org/10.1016/j.stemcr.2016.07.019SUMMARYControlled differentiation of human embryonic stem cells (hESCs) can be utilized for precise analysis of cell type identities during early
development. We established a highly efficient neural induction strategy and an improved analytical platform, and determined proteo-
mic and phosphoproteomic profiles of hESCs and their specifiedmultipotent neural stem cell derivatives (hNSCs). This quantitative data-
set (nearly 13,000 proteins and 60,000 phosphorylation sites) provides unique molecular insights into pluripotency and neural lineage
entry. Systems-level comparative analysis of proteins (e.g., transcription factors, epigenetic regulators, kinase families), phosphorylation
sites, and numerous biological pathways allowed the identification of distinct signatures in pluripotent and multipotent cells. Further-
more, as predicted by the dataset, we functionally validated an autocrine/paracrine mechanism by demonstrating that the secreted pro-
tein midkine is a regulator of neural specification. This resource is freely available to the scientific community, including a searchable
website, PluriProt.INTRODUCTION
Human pluripotent stem cells (hPSCs) enable modeling as-
pects of development and disease, and hold great promise
for regenerative medicine and drug discovery (van Hoof
et al., 2012; Young, 2011). Previous large-scale analyses of
hPSCs shed light on pluripotency, differentiation, and de-
differentiation by focusing on transcriptional regulation,
epigenetic changes, and non-coding RNAs (Boyer et al.,
2005; Brandenberger et al., 2004; Elkabetz et al., 2008;Mar-
tinez andGregory, 2010). However, proteomes contain vast
amounts of biological information unobtainable via geno-
mics, transcriptomics, or similar analyses (Wilhelm et al.,
2014). Thus, a detailed characterization of pluripotency,
lineage specification, and reprogramming by protein
profiling is important for complementing other analytical
methods and should help to elucidate novel mechanisms.
Regulation of proteins includes quantitative changes and
post-translational modifications (PTMs) (Huttlin et al.,
2010). A key PTM is reversible phosphorylation of serine
(pS), threonine (pT), and tyrosine (pY), which modulates
enzyme activities, protein-protein interactions, conforma-
tional changes, protein half-life, and signal transduction,This is an open access article under the Camong others (Choudhary and Mann, 2010). Multidimen-
sional liquid chromatography (MDLC) coupled with tan-
dem mass spectrometry (MS/MS) enables large-scale anal-
ysis of proteomes and phosphoproteomes (Huttlin et al.,
2010; Sharma et al., 2014). Although previous reports
have provided important insights into the proteomes of
hPSCs (Brill et al., 2009; Munoz et al., 2011; Phanstiel
et al., 2011; Rigbolt et al., 2011; Swaney et al., 2009; Van
Hoof et al., 2009; Van Hoof et al., 2006), none of these
studies have applied robustly controlled differentiation
strategies in feeder-free monolayer cultures. Hence, pro-
teomic analysis of pluripotent cells compared with their
lineage-specific multipotent derivatives has not been re-
ported. Moreover, previous datasets did not reach the
depth enabled by recent technical advances (Huttlin
et al., 2010; Sharma et al., 2014). Notably, label-free quan-
tification (LFQ) can yield deeper proteome coverage than
stable-isotope labeling by amino acids in cell culture while
maintaining quantitative accuracy (Collier et al., 2010;
Gokce et al., 2011; Sharma et al., 2014).
Here, we employed a controlled and reproducible neural
induction strategy to investigate the combined proteomic
and phosphoproteomic [termed (phospho)proteomic]Stem Cell Reports j Vol. 7 j 527–542 j September 13, 2016 j 527
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changes that occur when hESCs differentiate to a highly
pure population of hNSCs. These experiments also include
molecular and electrophysiological characterizations of
more differentiated cellular progeny, thereby confirming
the multipotency of the hNSCs studied. LFQ proteomic
methods allowed elucidation of cell type-specific (phos-
pho)proteomes at an unprecedented depth. To demon-
strate the utility of the dataset, we performed systems-level
analyses of cell-signaling pathways and protein families,
and created a map of epigenetic proteins, many of which
are regulated during differentiation. Our dataset includes
a large (phospho)proteomics resource of transcription
factors (n = 487) including previously unidentified phos-
phorylation sites on OCT4, NANOG, SOX2, and others.
Moreover, to demonstrate the utility of the dataset we per-
formed functional experiments showing that the secreted
protein midkine (MDK), which our (phospho)proteomic
analyses found to be upregulated during neural commit-
ment, instigates neural specification.RESULTS
Directed Differentiation of hPSCs to Enable
(Phospho)Proteomic Profiling of Neural Lineage
Commitment
Pluripotent cells were maintained under feeder-free mono-
layer conditions. For neural induction, exogenous fibroblast
growth factor (FGF2) was omitted from the culture medium
and a small-molecule cocktail (termed DAP; Figure 1A) was
added to suppress pathways that otherwise contribute to
pluripotency and/or non-neural differentiation of hESCs
(Boles et al., 2014; Chambers et al., 2009; Hasegawa et al.,
2012; Pera et al., 2004; Sturgeon et al., 2014). The 6-day
DAP treatment that we developed in our laboratory pro-
duced highly pure cultures of hNSCs (>97% PAX6+/NES-
TIN+ cells; Figures 1A and 1B). This neural induction
strategy was characterized by demonstrating: inhibition of
SMADphosphorylation sites (Figure S1A); induction of neu-
ral markers (Figures S1B, S1D, and S1F); downregulation of
pluripotency markers OCT4 and NANOG (Figures S1C and
S1F); absence of mesoderm (BRACHYURY), endoderm
(SOX17), neural crest (SOX10, TFAP2A, SNAI2), and non-
neural ectoderm (MSX1/2) (Figures S1F and S1G); compari-
son with embryoid body (EB) differentiation (Figure S1F);
immunostaining for PAX6/OTX2/NESTIN, normal karyo-
type; and efficient neuralization using human induced
PSCs (hiPSCs) (Figures 1A, S1H, and S1I).
hNSCs expanded in FGF2 for 30 days underwent ante-
rior-to-posterior specification, suggested by induction of
GBX2, DACH1, HOXA2, and HOXB4, and downregulation
of PAX6, PAX7, PLZF, and OTX1 (Figure S2A), consistent
with a previous report (Pankratz et al., 2007). To demon-528 Stem Cell Reports j Vol. 7 j 527–542 j September 13, 2016strate multipotency, we differentiated hNSCs into more
mature cell types representing the three main neural line-
ages (neurons, astrocytes, and oligodendrocytes; Figures
S2B–S2E). Moreover, neuronal activity was measured by
electrophysiological analyses. Spontaneous synaptic cur-
rents, action potential generation, and ion channel
response was observed when inhibitory (GABA) and excit-
atory (NMDA + glycine) stimuli were applied (Figure S3).
Together, these results show that highly pure hNSCs and
their more differentiated progeny were obtained from
6-day DAP treatment of hPSCs. Because the (phospho)pro-
teomes of hESCs grown under feeder-free conditions and
their earliest definitive neural derivatives expressing PAX6
(Pankratz et al., 2007; Zhang et al., 2010a) have not been
compared previously, we decided to perform this compara-
tive (phospho)proteome analysis.
Total (Phospho)Proteome Analysis Platform
(Phospho)proteins were digested to peptides and separated
by strong cation exchange chromatography (SCX) (Figures
1C and S4; Supplemental Experimental Procedures). Phos-
phopeptides were enriched from SCX fractions (Gandin
et al., 2013; Hou et al., 2013) (Figure 1C). Non-binding
and wash fractions (containing primarily non-phosphory-
lated peptides) and enriched phosphopeptides were sub-
jected to liquid chromatography (LC)-electrospray ioniza-
tion (ESI)-MS/MS, including optimized LC gradients (Hou
et al., 2013). MS/MS data was searched against a human
protein database and identifications were filtered at a pro-
tein-level false discovery rate (FDR) of <0.01 and peptide-
level FDR of <0.006 (Supplemental Experimental Proced-
ures). LFQ was by normalized spectral abundance factor
(NSAF) spectral counting (SpC) (Liu et al., 2004; Zhang
et al., 2010b), using non-phosphopeptides only, to
improve quantitative reliability (Supplemental Experi-
mental Procedures). Analysis of protein phosphorylation
included identification of phosphopeptides and phosphor-
ylation sites, and calculation of phosphopeptide spectral
counts (PSpCs). The PSpC is the number of MS/MS spectra
in a replicate that resulted in identification of a phospho-
peptide. Identifications employed ‘‘precision proteomics’’
(Choudhary and Mann, 2010) and additional high-confi-
dence analyses (Supplemental Experimental Procedures).
Variability of protein identifications was only 8.6%–
15.0% between replicates (Figure 1D). The number of
non-redundant phosphorylation sites is presented in Table
S1,whereas Tables S2–S16 are available at http://dx.doi.org/
10.17632/v7nt3wm8rk.1. Protein families are presented in
Tables S2–S7.Detailed information on all peptide andphos-
phopeptide identifications is given in Tables S8–S13. Bio-
logical data annotation is available at a searchable website,
http://pluriprot.org. Figure S5A illustrates how to access in-
formation on (phospho)proteins from our dataset. Protein
Figure 1. Controlled Neural Induction and Schematic Diagram of the (Phospho)Proteomic Workflow to Compare Human Plurip-
otency and Neural Multipotency
(A) Experimental approach for efficient 6-day neural conversion of hESCs into hNSCs using dorsomorphin, A83-01, and PNU-74654 (termed
DAP cocktail). Scale bars represent 100 mm.
(B) Fluorescence-activated cell sorting suggests virtually uniform conversion of hPSCs to PAX6+/NESTIN+ (NES+) hNSCs.
(C) Schematic diagram of the workflow for total (phospho)proteome analysis. Fr, fraction; RP, reversed-phase; LC, liquid chromatography;
ESI, electrospray ionization; LFQ, label-free quantification. ‘‘Precision proteomics’’ yields accurate results (Choudhary and Mann, 2010).
(D) Reproducibility of protein identification and quantification among experimental replicates was high.
See also Figures S1–S6.network analyses on PluriProt highlight pathways and bio-
logical processes enriched in hESCs or hNSCs (Figure S5B).
(Phospho)Proteins Detected in Pluripotent or
Multipotent Cells Only
Among the 13.6% of the proteins exclusively detected
in hESCs were proteins associated with pluripotency,
including ESRRB, UTF1, FOXO1, ALPI (alkaline phospha-
tase), TERT, and TDGF1 (Figures 2A, 2B, and 2E; Tables
S14A and S15A). In contrast, neural markers such asPAX6, PLZF, SOX5, SOX10, LHX1, SEZ6, and ARX were de-
tected in hNSCs only (Tables S14A and S15B). Notably,
76.4% of all detected proteins were phosphorylated (Fig-
ures 2A and 2B).
Analysis of Protein Abundance
First, a statistical test (t test) for proteomic data (Zybailov
et al., 2006) was used to analyze hESC/hNSC NSAF-SpC ra-
tios (termed E/N ratios). The mean E/N ratio for the dataset
was 1.27 and the median was 0.97, providing generalStem Cell Reports j Vol. 7 j 527–542 j September 13, 2016 529
Figure 2. Comparative Analysis of (Phospho)Proteomes of Pluripotent hESCs and Multipotent hNSCs
(A and B) Venn diagrams illustrating identification of all proteins, termed the (phospho)proteome and phosphorylated proteins in hESCs
(red; left portion of each diagram), hNSCs (brown; right portion of each diagram), and both cell populations (gray; overlap).
(C) Proteins with significantly differing relative abundance (t test, three replicates; p% 0.05) are represented as red, green, or brown dots,
whereas gray dots represent proteins with p > 0.05. LnNSAF is the mean natural log of the normalized spectral abundance factor (NSAF) for
the protein in either hESCs (Table S14, column J) or hNSCs (Table S14, column M).
(D) Process network analysis using differentially abundant proteins suggests distinctions in biological mechanisms between hESCs and
hNSCs. Network significance is shown by red bars (hESCs) or brown bars (hNSCs).
(E) Transcription factors more abundant in hESCs (red font; left panel), hNSCs (brown font; right panel), or without detected differences in
abundance (gray font; middle panel). SpC designates total spectral counts for the protein in both cell populations; 7* designates that
NANOG p = 0.00029 (three replicates, t test; Table S14A). N/A, not applicable. The number of localized pY sites (# of pY) and total number
(legend continued on next page)
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support for this approach. Second, themean E/N ratio of all
non-regulated ribosomal proteins in the dataset, 1.13, and
the SD (= 0.24; Table S14B) enabled significant difference
thresholds of an E/N ratio R2.00 or %0.50. These thresh-
olds are >3 SD from the mean, and should translate to ca.
p < 0.01 when the SpC threshold (R10; clarified below) is
met. Third, the natural log (Ln) of the NSAFs (Zybailov
et al., 2006; Table S14A) of the proteins was plotted (Fig-
ure 2C). Proteins with an E/N ratio differing significantly
between hESCs and hNSCs (t test; p < 0.05) are shown as
red, brown, and green dots in Figure 2C. Proteins expected
to be more abundant in hESCs with an E/N ratioR2.00 are
represented by red dots, whereas brown dots indicate those
expected to be more abundant in hNSCs, with an E/N ra-
tio %0.50 (Figure 2C). Green dots represent proteins with
0.50 < E/N ratio < 2.00. For example, HSPD1, with a signif-
icantly differing E/N ratio (1.56; p = 0.00063) was more
abundant in hESCs, whereas LIN28A (E/N ratio = 0.63;
p = 0.0020) wasmore abundant in hNSCs (Figure 2C). Inde-
pendent western blot experiments agreed with E/N ratios
(Figure S6A). However, in some cases the t test can miss
differentially abundant proteins (e.g., CTCF, Figure S6B),
consistent with a recent report (Gokce et al., 2011). Thus,
we propose that proteins with p > 0.05 but an E/N ratio
R2.00 or %0.50 (above) and SpC R10 in hESCs and/or
hNSCs (SpC threshold) should provide reliable informa-
tion on significant differences. False change rates for pro-
teins with SpC R10 were <1% in a previous report (Zhou
et al., 2010). Accordingly, protein quantification in the
dataset demonstrated high reproducibility (Figure S6C).
Furthermore, ‘‘housekeeping’’ proteins GAPDH, HPRT1,
and a-tubulin (TUBA1C) (E/N ratios of 0.81, 1.10, and
0.94, respectively) displayed similar relative abundance
(pluriprot.org), suggesting quantitative reliability.
Using these parameters, we identified protein networks
enriched in hESCs, including structural proteins (e.g., cyto-
skeleton, cell adhesion) and regulatory proteins (e.g., cell
cycle, anti-apoptotic; Figure 2D). Proteins enriched in
hNSCs were indicative of chromatin modification, neuro-
genesis, axonal guidance, cell adhesion, androgen receptor
signaling, and microtubules (Figure 2D).
Transcription Factors: Distinct Protein Abundance
and Phosphorylation Profiles in Pluripotent and
Lineage-Committed Cells
The dataset contains 487 transcription factors, with 416
identified in hESCs and 419 in hNSCs (Figure S6D),
including OCT4, NANOG, and PAX6, which serve as posi-of phosphorylation sites (total #p) are shown. Blue superscripts rep
proteins with phosphorylation in hESCs and hNSCs are in gold whenR
hESCs and hNSCs; otherwise superscripts are in gray. Green superscrip
See also Figures S6 and S7.tive controls (Figures 2C, 2E, S1C–S1F). Some proteins were
detected only via phosphopeptides (Figure 2E, SpC = 0),
suggesting enhanced sensitivity for detecting proteins
due to phosphopeptide enrichment, consistent with
another report (Huttlin et al., 2010).
Most transcription factors were phosphorylated (Figures
S6D and S6E; Tables S2–S7). Differential phosphorylation
of a protein includes at least one site detected in hESCs or
hNSCs only (e.g., LRRFIP1), detection of phosphorylation
in hESCs only (e.g., FOXO1), or detection of phosphoryla-
tion in hNSCs only (e.g., ENC1) (Figure 2E and Table S15).
In contrast, some proteins lacked differing phosphoryla-
tion sites (e.g., PTTG1). Repeated identification versus
lack of identification implies that the phosphopeptide is
likely to be more abundant in the cell population in which
it was identified (Brill et al., 2009). The PSpC of individual
phosphopeptides was between 1 and >100 (Figure S6F). In
addition, pY sites were identified on some transcription fac-
tors, e.g., OCT4 (Figure 2E).
Analysis of Kinases and Phosphorylation Motifs
The human genome encodes an estimated 518 protein ki-
nases (Manning et al., 2002), 479 of which (92.5%) were
detected in hESCs and hNSCs (Tables S2–S7). Among
200 phosphatases encoded by the human genome (Sacco
et al., 2012), the dataset contains 154 (77%); 144 phos-
phatases were detected in hESCs and 139 in hNSCs.
Receptor tyrosine kinases (RTKs) ERBB2, PDGFR, KDR,
and IGF1R promote pluripotency (Brill et al., 2009; Wang
et al., 2007). Differentially phosphorylated ERBB2 con-
tained 23 detected sites, two of which are pY (Table
S15C). IGF1R, KDR, and KITwere more abundant in hESCs
(Table S14A) and PDGFR, IGF1R, and KDR contained pY
sites (Tables S15A and S15C).
We detected 14 Ephrin RTKs, 13 ofwhichwere phosphor-
ylated, four with pY sites (Figure S6G). EPHA4 and EPHB2
contained detected phosphorylation in hNSCs only and
were upregulated in hNSCs. Among the five Ephrin ligands
that were detected, EFNB1 and EFNB2 weremore abundant
in hNSCs (Figure S6G). These findings suggest regulation of
Ephrin signaling when hESCs transition to hNSCs.
We determined 32 pS sequence motifs in the dataset and
predicted S/T kinases in the dataset phosphorylating these
motifs (Figure 3). Heatmap analysis suggests functions for
numerous S/T kinases in hESCs and hNSCs, including
GSK3a/b, CDKs, MAPK (ERK p38, JNK), AKT, mTOR, and
AURKA/B. Phosphorylated AURKA was more abundant
in hESCs (Figures 3 and S6B), in agreement with a role ofresent phosphorylation detection in hESCs only. Superscripts for
1 phosphorylation site detection on the protein differed between
ts represent phosphorylation detection in hNSCs only.
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Figure 3. S/T Kinases and Their Predicted Substrate Motifs
Motif-X (Schwartz and Gygi, 2005) was used to compute phosphopeptide sequence motifs from localized pS sites. The occurrence of motifs
is represented by bar graphs at the top (red, hESCs only; brown, hNSCs only; gray, both cell types). GPS 2.0 (Xue et al., 2008) was used to
predict and classify kinases (left) phosphorylating the pS motifs. The colors of kinase symbols (representative of relative abundance) and
superscripts (representative of phosphorylation) are defined in Figure 2E. See also Figure S6.Aurora A in sustaining pluripotency in mouse cells (Lee
et al., 2012). Hence, comparative kinome analysis in plurip-
otent and differentiated cells should enable testing of tar-
geted hypotheses.532 Stem Cell Reports j Vol. 7 j 527–542 j September 13, 2016Mapping Cell-Signaling Pathways
The dataset allowed identification of 415 biological path-
ways (Table S16). Transforming growth factor b (TGF-b)
and WNT pathways were examined because they are
incompletely characterized in pluripotency and early dif-
ferentiation, and were modulated by the DAP protocol.
Coverage of (phospho)proteins in the canonical TGF-b
and WNT pathways was 81% and 89%, respectively (Fig-
ures 4A and 4B). Many of these proteins displayed differen-
tial abundance and/or phosphorylation. Comparative
analysis highlighted (phospho)proteins participating in
the regulation of pluripotency and neural conversion
(e.g., ID1, LEFTY1, LEFTY2). Additional pathway analyses
were performed for Nodal and Notch signaling (Figures
S7A and S7B). These examples illustrate that the dataset en-
ables global pathway analysis (Table S16).
Abundance and Phosphorylation of Epigenetic
Proteins
Pluripotency is characterized by open chromatin, which is
maintained by structural proteins, histone, and DNAmod-
ifications that affect gene silencing and activation, whereas
lineage commitment of pluripotent cells results in hetero-
chromatin formation (Orkin and Hochedlinger, 2011;
Zhu et al., 2013). We reasoned that uniform neural induc-
tion is ideal for comparison of the (phospho)proteomic
state of epigenetic regulators in pluripotent and multipo-
tent cells. The dataset contains at least 273 proteins
involved in epigenetic changes and chromatin modifica-
tions (Figure 5). Eighty-seven percent contained identified
phosphorylation, including 33% with pY sites (Figure 5,
magenta circles).
Previous epigenetic protein characterizations were per-
formed mostly in rodent models. The Polycomb repressive
complex 2 (PRC2), containing SUZ12, EZH2, and EED, plays
an important role in establishing ‘‘bivalent domains’’ in
pluripotent cells that keep developmental genes silent but
poised for expression upon differentiation (Young, 2011).
All PRC2 proteins were phosphorylated in hESCs, and
EZH2 and EED were phosphorylated in hNSCs (Figure 5
and Table S15B). The relative abundance of these proteins
was similar tochangesdescribedduringmousedevelopment
(Meissner, 2010). SUZ12 and EZH2 were more abundant in
hESCs, whereas EED was more abundant in hNSCs. Other
examples of epigenetic regulators are DNMT3B, JARID2,
andCHD1,whichweremore abundant andphosphorylated
in hESCs (e.g., pY404 on DNMT3B; pY225 on CHD1).
Non-histone, chromatin-associated high-mobility group
(HMG) proteins participate in transcriptional regulation
and changes in DNA conformation (Bianchi and Agresti,
2005). The dataset contains 11 HMG proteins, with
HMGB2 upregulated in hNSCs (Figure S6B). Neuronal dif-
ferentiation is initiated by overcoming the repression by
REST, thereby inducing neural-specific genes inmouse cells
(Bianchi and Agresti, 2005). Consistently, REST was down-
regulated in hNSCs (Figure 2E). The chromatin insulator
CTCF is a key genome organizer that can block the interac-tion of enhancer elements with unrelated promoters in
mouse cells (Handoko et al., 2011). CTCF was more abun-
dant in hNSCs, as measured byMDLC-MS/MS and western
blots (Figures 5 and S6B). The heterochromatin protein
HP1BP3 was upregulated in hNSCs (www.pluriprot.org).
Validation of (Phospho)Proteomic Data Suggest a
Functional Role for MDK During Neural
Differentiation
Although progress has beenmade (Boles et al., 2014; Cham-
bers et al., 2009), our understanding of the mechanisms of
neural fate choice from hESCs remains incomplete. Since
secreted proteins may contribute to cell differentiation,
we focused on protein ligands present in our dataset (Tables
S2–S7). Among these, MDK was strongly upregulated in
hNSCs (Figure 2C). MDK was identified in differentiating
teratocarcinoma cells and is expressed in the mouse neural
tube duringmid-gestation (Muramatsu, 2011; Uehara et al.,
1992). Although MDK was detected in the secretome of
hESCs (Bendall et al., 2009), its functional role has not
been studied in hPSCs. MDK is expressed by undifferenti-
ated hPSCs and upregulated when hESCs and hiPSCs are
differentiated using the EB method or controlled 6-day
DAP treatment (Figures 6A and 6B). Upregulation of MDK
in hNSCs (Figure 2C) was confirmed by western blots
(Figure 6B). MDK was absent from skin fibroblasts (FB) but
induced during cellular reprogramming (FB-hiPSC).
We askedwhether inhibitionofMDK signaling by an anti-
MDK monoclonal antibody has functional consequences
for pluripotency and/or neural differentiation. hESCs were
cultured in the presence of anti-MDKor isotype control anti-
body.Anti-MDKdidnotdetectablyaffectpluripotentgrowth
of hESCs, as measured by alkaline phosphatase staining and
expression of OCT4 and NANOG (Figures 6C and 6D).
However, when anti-MDK was applied during 6-day neural
induction, upregulation of OTX1, PAX6, and PLZF mRNAs
was impaired (Figure 6E) and neural protein expression was
strongly suppressed (Figures 6F and 6G). We also tested
whether MDK promotes mesodermal and endodermal line-
age commitment. Experiments using recombinant MDK
aloneor incombinationwiththeDAPcocktaildemonstrated
that non-neural markers SOX17, BRACHYURY, and MIXL1
were not induced by MDK but detected in controls treated
with fetal bovine serum (Figure 6H). Furthermore, MDK
alone partially induced expression of PAX6 in hESCs but,
remarkably, MDK in combination with DAP resulted in
earlier and stronger expression of PAX6 compared with
DAP treatment alone (Figure 6H).
Genetic Knockdown of MDK Efficiently Blocks Neural
Conversion of Pluripotent Human Cells
To validate that increased MDK expression is important for
neural induction, we performed knockdown of MDK inStem Cell Reports j Vol. 7 j 527–542 j September 13, 2016 533
(legend on next page)
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hESCs using retroviral short hairpin RNAs (shRNAs). Four
stable cell lines with scrambled control shRNA and two
cell lines with efficient MDK knockdown were analyzed
by western blotting and immunocytochemistry (Figures
7A–7C). We did not detect differences in self-renewal
when hESC lines with scrambled control shRNA or MDK
knockdown were expanded in parallel with parental
hESCs, similar to the use of anti-MDK antibodies (Figures
6C and 6D). However, when hESCs were treated with
DAP for 6 days, PAX6 expression was blocked in both cell
lines with MDK knockdown but not in scrambled shRNA
controls (Figures 7A–7D). These findings, together with ex-
periments using the anti-MDK antibody (Figures 6E–6G),
support the notion that upregulation of MDK is necessary
for neural lineage entry of hESCs. Collectively, these results
suggest that suppression of TGF-b, bone morphogenetic
protein (BMP), and WNT signaling (the rationale for using
the DAP cocktail) and the action of autocrine/paracrine
MDK are important mechanisms of early neural specifica-
tion (Figures 4, 6, and 7).
Complementary Analysis of Neural Induction by
Transcriptomic and Proteomic Datasets
Transcriptomic data from the same well-defined cell popu-
lations was obtained to gain additional insights into gene
regulation in pluripotent and multipotent cells. Among
the 9,635 genes whose products were identified as mRNAs
and proteins, changes in the relative abundance of cognate
mRNAs and proteins displayed concordance and discor-
dance (Figure S7C). Overall correlation in changes between
both datasets was only r = 0.40. This may reflect the impor-
tance of protein translation, stability, and PTMs as part of
the regulatory mechanisms that are integrated with epige-
netic and transcriptional changes during the switch of
cellular identities. The complexity of these coordinated
events has been reported in murine ESCs (Lu et al., 2009;
Sampath et al., 2008). Hence, combined analysis of
proteomic and transcriptomic data is desirable for precise
characterization of cell type identities during differentia-
tion and reprogramming (Benevento et al., 2014). The
use of both methods allowed the identification of a larger
number of significant biological processes than either
alone. Cell type-specific biological processes segregated
more clearly when using the proteomic dataset (Figures
2D and S7D).Figure 4. Mapping TGF-b and WNT pathways in hESCs and hNSCs
(Phospho)proteomic data revealed most components of the canonical
in hESCs are in red and those more abundant in hNSCs in brown. Prote
not detected are in white. Numbers adjacent to the proteins indicate
same colors as the superscript font in Figure 2E. Magenta bands represe
of non-redundant phosphorylation sites. Seven TCF and 14 PRKA prot
TCF and PRKA phosphorylation is not shown). See also Figure S7.DISCUSSION
To our knowledge, uniformly differentiated, lineage-
committed cells derived from hESCs have not been
analyzed previously by proteomics. Our data provided in-
sights into the molecular complexity of pluripotency and
cell differentiation, and captured specific (phospho)proteo-
mic signatures in direct comparisons of hESCs and hNSCs.
The data shed light on cell-signaling pathways and the
human kinome, and established an expanded resource of
epigenetic proteins.
The dataset allows a well-defined comparison of protein
abundance and phosphorylation in pluripotent cells and
the earliest definitive hNSCs. This contrasts with previous
studies that used hESCs and heterogeneous mixtures of
differentiated progeny (Brill et al., 2009; Rigbolt et al.,
2011; Van Hoof et al., 2009), or hESCs only (Swaney
et al., 2009). Another study compared hESCs and hiPSCs,
reporting 6,761 proteins and 19,122 phosphorylation sites
(Phanstiel et al., 2011). A proteomic analysis of the mem-
brane fraction of hESCs and heterogeneous cells enriched
for NSCs, derived by EB differentiation, yielded 5,105 pro-
teins and 8,560 phosphorylation sites (Melo-Braga et al.,
2014). In contrast, we used whole-cell lysates from hESCs
and their hNSC derivatives at high purity under feeder-
free conditions. Importantly, we did not passage the cells
during hNSC induction, so as to capture unperturbed
(phospho)proteomic profiles when pluripotent cells transi-
tion to the neural lineage.We report nearly 13,000 proteins
(Figure 2A), most of which were phosphorylated at nearly
60,000 non-redundant sites (Table S1), revealing a striking
depth of (phospho)proteomes and biological pathways.
The dataset contains most previously published (phos-
pho)proteins in hPSCs, plus more not reported in those
studies (Figures S7E–S7H). In addition, our results suggest
previously unknown reproducibility of the hPSC phospho-
proteome via comparison with these datasets.
Phosphorylated transcription factors are prominent in
hESCs (Brill et al., 2009; Rigbolt et al., 2011; Van Hoof
et al., 2009). Our current dataset represents progress toward
comprehensive (phospho)proteomic mapping of tran-
scription factors. Rigbolt et al. (2011) found that 83.8% of
216 detected transcription factors were phosphorylated.
Similarly, 75.1% of the 487 transcription factors in our
dataset were phosphorylated. OCT4 phosphorylation onTGF-b (A) and WNT (B) signaling pathways. Proteins more abundant
ins without detected differences in abundance are in gray. Proteins
the E/N ratio. Circles represent protein phosphorylation, with the
ntR1 pY site. Larger circles represent proteins with larger numbers
eins were detected (B), respectively (Tables S15A–S15C; for clarity,
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pT234 and pS235 disrupts its binding to DNA (Brumbaugh
et al., 2012). Phosphorylation sites pT225 and pY291 (Table
S15A), to the best of our knowledge, have not been identi-
fied previously on OCT4. Our dataset also contains two
phosphorylation sites on NANOG (pS10 and pS52). In
addition, 12 phosphorylation sites were detected on
SOX2, five of which were not reported previously (pY2,
pT7, pT17 or pS18, pS257, and pS290). These and other ex-
amples suggest the importance of post-translational regula-
tion of transcription factors, which is understudied.
Dual SMAD inhibition andmodulation ofWNTsignaling
is important for neural conversion of hPSCs, as indicated
previously (Chambers et al., 2009; Hasegawa et al., 2012)
and by the present study (Figure 1A). NPTX1 plays a role
in neural lineage specification from hESCs by reducing
NODAL and BMP signaling (Boles et al., 2014), suggesting
that NPTX1 further contributes to dual SMAD inhibition
(Chambers et al., 2009). However, it remained unclear
whether neural induction is regulated by other signals.
The secreted protein MDK is an instructive component of
neural lineage entry (Figure 7E). Blocking MDK by genetic
knockdown and amonoclonal antibody provided indepen-
dent evidence for amechanismbywhich feedforward upre-
gulation of MDK promotes neural induction, consistent
with MDK resulting in specific upregulation of PAX6 (Fig-
ures 6 and 7). MDK may act through a receptor complex
that can includeALK, PTPRZ1, LRP1, andSDC1 (Kadomatsu
et al., 2013;Muramatsu, 2011). PTPRZ1wasmore abundant
in hESCs, whereas LRP1 wasmore abundant in hNSCs (Fig-
ure 7E). Although MDK was reported 26 years ago (Tomo-
mura et al., 1990), MDK and its receptors remain under-
studied. Hence, the finding that MDK plays a role in PSC
differentiation requires detailed follow-up studies.
Collectively, our methods and dataset are resources to
leverage diverse studies including further elucidation of
pluripotency, differentiation, and reprogramming. The da-
taset may also prove useful for comparison with stem cells
from non-mammalian models. For example, orthologs of
all proteins in the COP9 complex in Drosophila germline
stem cells (Pan et al., 2014) are in our dataset. We high-
lighted several analyses that the dataset enables and pro-
vided proof of principle for its predictive value. We make
this resource freely available to the scientific community
as curated tables, an interactive website (www.pluriprot.
org), and raw data in the Peptide Atlas database (Institute
for Systems Biology).Figure 5. (Phospho)Proteome of Epigenetic Regulators in hESCs
Proteins represented as circles were phosphorylated, whereas triangle
respectively). Red or brown represents higher relative protein abundan
difference in the abundance of the protein was detected. Numbers in
phosphorylation between cell types as described for Figures 2E and 4.
Figure S6.EXPERIMENTAL PROCEDURES
Cell Culture
Pluripotent cells were cultured under feeder-free conditions on
Matrigel with MEF-CM and FGF2. For neural induction, uncondi-
tioned medium and 2 mM dorsomorphin, 2 mM A83-01, and
2 mM PNU-74654 (DAP cocktail) were added. A retrovirus-based
protocol (Takahashi et al., 2007) was modified to generate hiPSCs.
Details are provided in Supplemental Experimental Procedures.
Immunocytochemistry, Fluorescence-Activated Cell
Sorting, and Western Blots
For immunocytochemistry, cells were fixed in 4% paraformalde-
hyde and stained with the antibodies listed in Supplemental
Experimental Procedures. Fluorescence-activated cell sorting
analysis (Pankratz et al., 2007) and western blots (Brill et al.,
2009) were as described previously. Details, including procedures
for immunoprecipitations, are provided in Supplemental Experi-
mental Procedures.
Knockdown of MDK by shRNA
hESCs were transduced with either MDK or scrambled control
shRNA, and drug selection with puromycin and kanamycin was
used to establish stable cell lines.
MDK Inhibition by a Monoclonal Antibody
Medium with either anti-MDK or isotype control antibodies was
added daily with the DAP cocktail for 6 days.
Transcriptome Analysis
Illumina HumanHT-12 Expression Arrays were analyzed using
a BeadArray Reader. Data were collected using the scanner soft-
ware. Sample probe files were obtained using GenomeStudio after
expression intensities were calculated and quality controlled with
detection p values of %0.05 for each gene probe. Differentially
expressed genes were detected in GeneSpring GX 11.5 by quantile
normalization, log transformation, t tests with Benjamini-
Hochberg corrected p value of%0.05, and fold-change difference
ofR2.0.
Total (Phospho)Proteome Work Flow
Approximately 4 3 107 hESCs or hNSCs were rinsed with PBS and
lysed. Lysates were centrifuged, (NH4)2SO4 added to supernatants,
mixtures agitated at 4C, and centrifuged. Protein pellets were
stored at 80C. Pellets were resuspended in 100 mM (NH4)2-
HCO3/8 M urea containing protease and phosphatase inhibitors
and gel filtered, and protein concentrations measured. Protein
(1 mg) was reduced, alkylated, digested with trypsin, peptides de-
salted, dried, and stored at 80C.and hNSCs
s represent proteins lacking identified phosphorylation (P and NP,
ce in hESCs or hNSCs, respectively. Gray indicates that no significant
dicate the E/N ratio. Colors of circular bands indicate comparative
Symbols of proteins in bold font are mentioned in the text. See also
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Figure 6. MDK Expression in Pluripotent and Differentiated Cells and Disruption of Neural Conversion by a Monoclonal Antibody
against MDK
(A) Representative immunocytochemical analysis of MDK expression by hESCs (WA09), skin fibroblasts (FB, line HS27), and fibroblasts
(HS27) after reprogramming to hiPSCs. Scale bars represent 100 mm.
(B) Western blot showing that MDK was not detected in HS27 fibroblasts but was expressed in WA09 hESCs and hiPSCs from HS27
fibroblasts, and was upregulated in differentiating cells (EBs and hNSCs from hESCs). Probing for GAPDH demonstrated similar loading of
the lanes.
(C) A monoclonal antibody against MDK did not impair pluripotent self-renewal of hESCs. Antibody concentrations are shown.
(legend continued on next page)
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Figure 7. MDK Knockdown Validates the Importance of MDK Upregulation for Neural Fate Specification of hESCs
(A) Western blot analysis of MDK in control H9-hESC lines (scrambled shRNA) and H9-hESC lines with MDK knockdown (left panel).
Quantification (right panel) confirmed efficient MDK knockdown.
(B and C) Immunocytochemical analysis of MDK in control hESCs (scrambled shRNA) (B) and hESCs with MDK shRNA (C) confirmed efficient
MDK suppression in the cells containing MDK shRNA. Scale bars represent 100 mm.
(D) Controls and cell lines with MDK knockdown were treated with DAP for 6 days. PAX6 was inhibited in cell lines with MDK knockdown,
whereas PAX6 was expressed in scrambled shRNA controls.
(E) Model proposed for controlled neural induction of hESCs, depicting the simultaneous modulation of cell-signaling pathways and a role
for MDK. The (phospho)proteomic dataset also suggests changes in relative abundance and phosphorylation of putative MDK receptors
(ALK, PTPRZ1, SDC1, and LRP1) in hESCs and hNSCs. Colors are as described in Figure 2E and the sizes of letters reflect E/N and PSpC ratios.Peptides were separated by SCX, desalted, and dried. Phospho-
peptides were enriched from SCX fractions. LC-ESI-MS/MS was
performed on each fraction in duplicate with a C18 column,
captive spray source, and LTQ Orbitrap Velos mass spectrometer
with electron-transfer dissociation.
MS/MS data were searched against a concatenated forward and
reverse ipi.HUMAN.v.3.73 database with Sorcerer-SEQUEST. Static(D) The percentage of pluripotent cells expressing OCT4 and NANOG
antibody treatment (3.0 mg/mL). Error bars represent SEM; n = 5.
(E) qRT-PCR showed that a monoclonal antibody against MDK (1.5 mg
Error bars represent mean + SEM, n = 3. *p < 0.05.
(F) Western blot analysis confirmed the inhibitory effect of anti-M
treatment, in contrast to the isotype control.
(G) Immunocytochemical evidence that neural conversion is inhibited
Few cells induced PAX6 expression in the presence of anti-MDK antib
(H) Western blot analysis and time course of hESCs differentiated for 6
the DAP cocktail and MDK (25 or 100 ng/mL) suggest that MDK spec
Brachyury were not induced by MDK. In contrast, controls treated with
differentiation of hPSCs, induced these non-neural markers.carbamidomethylation of C, differential oxidation of M, and dif-
ferential phosphorylation of S, T, and Y were specified. Protein
identifications were filtered at an FDR of <0.01 (ProteinProphet),
including stringent phosphopeptide-level verification (Supple-
mental Experimental Procedures). NSAF-SpCs (Zhang et al.,
2010b), Ln-NSAFs (Zybailov et al., 2006), and PSpCs were
calculated.did not differ significantly between anti-MDK and isotype control
/mL) inhibits neural gene expression during 6-day DAP treatment.
DK on early neural marker expression (OTX1, PAX6), despite DAP
by the anti-MDK antibody (1.5 mg/mL) during 6-day DAP treatment.
ody (right panel). Scale bar represents 200 mm.
days with recombinant MDK alone (100 ng/mL) or a combination of
ifically promotes neural commitment of hPSCs. SOX17, MIXL1, and
fetal bovine serum (FBS) for 6 days, which stimulates multi-lineage
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(Phospho)Proteomic Data Mining
Cell-signaling pathways, protein networks, and interaction maps
were analyzed and processed using KEGG, Ingenuity, GeneGO,
Cytoscape, and Adobe Photoshop. Phosphorylation motifs and
kinase predictions were as described previously (Schwartz and
Gygi, 2005; Xue et al., 2008) and displayed with Treeview (Salda-
nha, 2004), and predicted kinases not in the dataset were removed
(Figure 3).
Supplemental Material
Table S1 is included in the Supplemental Information, and
Tables S2–S16 can be downloaded at http://dx.doi.org/10.17632/
v7nt3wm8rk.1. Interactive analysis of the proteomic dataset can
be performed by searching for specific proteins of interest (enter
protein name on Homepage) and accessing Network diagrams
(Networks): http://pluriprot.org.
Source Data
Tables S2–S16: http://dx.doi.org/10.17632/v7nt3wm8rk.1.
ACCESSION NUMBERS
The (phospho)proteome data can be accessed on the websites
specified above, and all raw data are deposited in the Peptide Atlas
(accession number PASS00233; https://db.systemsbiology.net/
sbeams/cgi/PeptideAtlas/PASS_View?identifier=PASS00233; Insti-
tute for Systems Biology).
Transcriptomic data are in the Gene Expression Omnibus, acces-
sion number GEO: GSE39876.
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Procedures, seven figures, and 16 tables and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2016.
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